Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Andro Does Not Boost Muscle Mass Or Serum Testosterone Levels - Study

This article was originally published in The Tan Sheet

Executive Summary

Androstenedione supplementation "does not increase serum testosterone concentrations or enhance skeletal muscle adaptations to resistance training in normo-testosterogenic young men and may result in adverse health consequences," Douglas King, PhD, Iowa State University, et al., report in the June 2 Journal of the American Medical Association.

You may also be interested in...



FDA/DEA Ban Of Andro Sought By Blue Cross & Blue Shield Foundation

A youth sports advocacy group is attempting to halt the sale and use of androstenedione-containing dietary supplements with a dual-pronged initiative aimed at Major League Baseball players and federal regulators, including FDA.

FDA/DEA Ban Of Andro Sought By Blue Cross & Blue Shield Foundation

A youth sports advocacy group is attempting to halt the sale and use of androstenedione-containing dietary supplements with a dual-pronged initiative aimed at Major League Baseball players and federal regulators, including FDA.

FDA/DEA Ban Of Andro Sought By Blue Cross & Blue Shield Foundation

A youth sports advocacy group is attempting to halt the sale and use of androstenedione-containing dietary supplements with a dual-pronged initiative aimed at Major League Baseball players and federal regulators, including FDA.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089893

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel